高级检索
    谢琳, 高惠冰. 帕博利珠单抗治疗MSI-H/dMMR晚期结直肠癌的疗效和安全性[J]. 循证医学, 2020, 20(4): 213-216. DOI: 10.12019/j.issn.1671-5144.2020.04.004
    引用本文: 谢琳, 高惠冰. 帕博利珠单抗治疗MSI-H/dMMR晚期结直肠癌的疗效和安全性[J]. 循证医学, 2020, 20(4): 213-216. DOI: 10.12019/j.issn.1671-5144.2020.04.004
    shu
    XIE Lin, GAO Hui-bing. The Efficacy and Safety of Pembrolizumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 213-216. DOI: 10.12019/j.issn.1671-5144.2020.04.004
    Citation: XIE Lin, GAO Hui-bing. The Efficacy and Safety of Pembrolizumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 213-216. DOI: 10.12019/j.issn.1671-5144.2020.04.004
    shu

    帕博利珠单抗治疗MSI-H/dMMR晚期结直肠癌的疗效和安全性

    The Efficacy and Safety of Pembrolizumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer

      摘要
      • HTML全文
      • 参考文献(8)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回